Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

1
results for

"Transferrin"

Article category

Keywords

Publication year

"Transferrin"

Original Article

Viral hepatitis

Serum transferrin as a liver fibrosis biomarker in patients with chronic hepatitis B
Hyo Jung Cho, Soon Sun Kim, Seun Joo Ahn, Joo Han Park, Dong Joon Kim, Young Bae Kim, Sung Won Cho, Jae Youn Cheong
Clin Mol Hepatol 2014;20(4):347-354.
Published online December 24, 2014
DOI: https://doi.org/10.3350/cmh.2014.20.4.347
Background/Aims

Transferrin and alpha-1 antitrypsin are reportedly associated with liver fibrosis. We evaluated the usefulness of serum transferrin and alpha-1 antitrypsin as new liver fibrosis markers in patients with chronic hepatitis B.

Methods

The study included 293 patients with chronic hepatitis B who underwent a liver biopsy between October 2005 and June 2009, and who had no history of hepatocellular carcinoma. Serum markers and liver fibrosis stages were compared.

Results

Univariate analysis revealed that age (P<0.001), serum platelet count (P<0.001), and serum alkaline phosphatase level (P=0.003) differed significantly between the patients with and without liver cirrhosis. Serum transferrin levels were significantly lower in advanced fibrosis than in mild fibrosis in both univariate analysis (P=0.002) and multivariate analysis (P=0.009). In addition, the serum transferrin level was significantly lower in cirrhotic patients than in noncirrhotic patients (P=0.020). However, the serum level of alpha-1 antitrypsin was not significantly associated with liver cirrhosis in patients with chronic hepatitis B.

Conclusions

Serum transferrin could be promising serum marker for predicting advanced liver fibrosis in patients with chronic hepatitis B.

Citations

Citations to this article as recorded by  Crossref logo
  • Ellagic acid alleviates iron overload-induced liver damage by mitigating ferroptosis through modulation of the TGFβ/Smad signaling pathway
    Hangjie Fu, Wenxia Li, Qimei Cheng, Zhiwei Weng, Zhiguang Huang, Lijian Zhu, Tao Ding, Bin Ding
    Food Research International.2025; 214: 116590.     CrossRef
  • Evaluation of Transferrin Level in Iron Supplementation after Partial Hepatectomy
    Weiwei Fang, Chang Pang, Xiying Li
    Bulletin of Experimental Biology and Medicine.2025; 179(3): 348.     CrossRef
  • Iron Metabolism Genes Shape the Course of Liver Fibrosis in Chronic Hepatitis C: From Disease Progression to Reversal After Direct-Acting Antivirals Treatment
    Joana Ferreira, Manuel Bicho, Paula Faustino, Fátima Serejo
    Viruses.2025; 17(10): 1302.     CrossRef
  • Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
    Min-Jun Liao, Jun Li, Wei Dang, Dong-Bo Chen, Wan-Ying Qin, Pu Chen, Bi-Geng Zhao, Li-Ying Ren, Ting-Feng Xu, Hong-Song Chen, Wei-Jia Liao
    World Journal of Gastroenterology.2022; 28(27): 3503.     CrossRef
  • Proteomic and molecular evidences of Il1rl2, Ric8a, Krt18 and Hsp90b1 modulation during experimental hepatic fibrosis and pomegranate supplementation
    Hadiya Husain, Mohammad Waseem, Riaz Ahmad
    International Journal of Biological Macromolecules.2021; 185: 696.     CrossRef
  • Identification and characterization of substrates crosslinked by transglutaminases in liver and kidney fibrosis
    Hideki Tatsukawa, Taishu Takeuchi, Yoshiki Shinoda, Kiyotaka Hitomi
    Analytical Biochemistry.2020; 604: 113629.     CrossRef
  • Serum Transferrin Is an Independent Predictor of Mortality in Severe Alcoholic Hepatitis: Upping the Game or Just Upping the Ante?
    Kedhara G. Sainath, Arun Vasan, Virendra Singh
    American Journal of Gastroenterology.2020; 115(7): 1136.     CrossRef
  • Hepatic transferrin plays a role in systemic iron homeostasis and liver ferroptosis
    Yingying Yu, Li Jiang, Hao Wang, Zhe Shen, Qi Cheng, Pan Zhang, Jiaming Wang, Qian Wu, Xuexian Fang, Lingyan Duan, Shufen Wang, Kai Wang, Peng An, Tuo Shao, Raymond T. Chung, Shusen Zheng, Junxia Min, Fudi Wang
    Blood.2020; 136(6): 726.     CrossRef
  • Progress of non-invasive diagnostic of liver fibrosis: review of modern laboratory methods
    E. A. Kulebina, A. N. Surkov
    Meditsinskiy sovet = Medical Council.2020; (11): 224.     CrossRef
  • Early urinary candidate biomarker discovery in a rat thioacetamide-induced liver fibrosis model
    Fanshuang Zhang, Yanying Ni, Yuan Yuan, Wei Yin, Youhe Gao
    Science China Life Sciences.2018; 61(11): 1369.     CrossRef
  • Clinical significance of decoy receptor 3 upregulation in patients with hepatitis B and liver fibrosis
    Xiaoli Lou, Yanqiang Hou, Hui Cao, Jingjing Zhao, Fengting Zhu
    Oncology Letters.2018;[Epub]     CrossRef
  • Low transferrin and high ferritin concentrations are associated with worse outcome in acute liver failure
    Olympia E. Anastasiou, Julia Kälsch, Mahdi Hakmouni, Ozlem Kucukoglu, Dominik Heider, Johannes Korth, Paul Manka, Jan‐Peter Sowa, Lars Bechmann, Fuat H. Saner, Andreas Paul, Guido Gerken, Hideo A. Baba, Ali Canbay
    Liver International.2017; 37(7): 1032.     CrossRef
  • Automated microfluidic platform of bead-based electrochemical immunosensor integrated with bioreactor for continual monitoring of cell secreted biomarkers
    Reza Riahi, Seyed Ali Mousavi Shaegh, Masoumeh Ghaderi, Yu Shrike Zhang, Su Ryon Shin, Julio Aleman, Solange Massa, Duckjin Kim, Mehmet Remzi Dokmeci, Ali Khademhosseini
    Scientific Reports.2016;[Epub]     CrossRef
  • Identification of Candidate Serum Biomarkers for Schistosoma mansoni Infected Mice Using Multiple Proteomic Platforms
    Manal I. Kardoush, Brian J. Ward, Momar Ndao, Salah A Sheweita
    PLOS ONE.2016; 11(5): e0154465.     CrossRef
  • Proteomic profiling of HBV infected liver biopsies with different fibrotic stages
    Seyma Katrinli, Kamil Ozdil, Abdurrahman Sahin, Oguzhan Ozturk, Gozde Kir, Ahmet Tarik Baykal, Emel Akgun, Omer Sinan Sarac, Mehmet Sokmen, H. Levent Doğanay, Gizem Dinler Doğanay
    Proteome Science.2016;[Epub]     CrossRef
  • Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis
    Hiroto Kayashima, Takashi Maeda, Noboru Harada, Takanobu Masuda, Atsushi Guntani, Shuhei Ito, Ayumi Matsuyama, Motohiro Hamatake, Shinichi Tsutsui, Hiroyuki Matsuda, Teruyoshi Ishida
    Surgery.2015; 158(6): 1669.     CrossRef
  • Current strategies and findings in clinically relevant post-translational modification-specific proteomics
    Oliver Pagel, Stefan Loroch, Albert Sickmann, René P Zahedi
    Expert Review of Proteomics.2015; 12(3): 235.     CrossRef
  • Non-invasive diagnosis of liver fibrosis and cirrhosis
    Yoav Lurie
    World Journal of Gastroenterology.2015; 21(41): 11567.     CrossRef
  • 12,163 View
  • 132 Download
  • 19 Web of Science
  • Crossref